About VORTA
VORTA is a company based in Pune (India) founded in 2015. It operates as a Product-as-a-Service. VORTA offers products and services including Vortex Cavitation Reactor and Process Stream Optimization. VORTA operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Annual Revenue₹43.7 Lakh
FY 2025 · -43% YoY
- Net Profit₹7.1 Lakh
FY 2025 · 16% margin
- EBITDA₹10.6 Lakh
FY 2025 · 24% margin
Associated legal entities of VORTA
VORTA operates through Vivira Process Technologies Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Vivira Process Technologies Private Limited CIN U74900PN2015PTC154118 | Active | 24 Feb 2015 | Pune, Maharashtra | ₹0.4 Cr | – | 3 | View details |
Products & Services of VORTA
VORTA offers a comprehensive portfolio of products and services, including Vortex Cavitation Reactor and Process Stream Optimization.
A reactor enhancing efficiency in manufacturing processes.
Optimization of streams for better resource utilization.
Apps and channels of VORTA
its YouTube channel VORTA_TECH has 8 subscribers and 1 videos.
Videos from VORTA
The most watched videos on VORTA's YouTube channel, VORTA_TECH (8 subscribers). Click a video to play it here.
More on VORTA_TECH.
Funding Insights of VORTA
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of VORTA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2019 | – | Angel Round | $36,837 | Swati Pramod Ranade | – |
Last known valuation $36,837 (Dec 2019). 1 investors in total: 0 institutional and 1 angel.
Investors in VORTA
VORTA has secured backing from 1 investor, including angel investors. Prominent investors backing the company include Swati Pramod Ranade.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
SP Swati Pramod Ranade | - | – | unknown_b50ab4e007b1467d8 | - |
Investor details for VORTA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Vivira Process Technologies Private Limited (VORTA)
Vivira Process Technologies Private Limited is the primary company behind VORTA. The board of Vivira Process Technologies Private Limited currently have 3 directors; the longest-serving is Vivek Vinayak Ranade, appointed in 2015. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vivek Vinayak Ranade DIN 00104690 | Director | 24 Feb 2015 | 11 yrs 7 mo | Vivira Process Technologies Private Limited |
| Ranjeet Pandurangrao Utikar DIN 00104604 | Director | 24 Feb 2015 | 11 yrs 7 mo | Vivira Process Technologies Private Limited |
| Swati Pramod Ranade DIN 07575158 | Director | 25 Jul 2016 | 10 yrs 2 mo | Vivira Process Technologies Private Limited |
Financials of VORTA
Figures of Vivira Process Technologies Private Limited, the primary company behind VORTA, for FY 2025. Revenue was ₹43.7 Lakh (-43% year on year). Net profit was ₹7.1 Lakh (16% margin). EBITDA was ₹10.6 Lakh (24% margin). Revenue has grown at a compounded annual rate of +108% over three years and -5% over five years.
- ₹43.7 LakhRevenue · FY 2025 · -43% YoY
- ₹7.1 LakhNet profit · 16% margin
- ₹10.6 LakhEBITDA · 24% margin
- ₹1 LakhPaid-up capital
- +108%Revenue CAGR, 3 years
- -5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Vivira Process Technologies Private Limited are on its company page.
Detailed financial statements for VORTA
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of VORTA
2 dated milestones of VORTA across 4 years, from founding to its latest funding, stage changes and deals.
- Founded VORTA is founded.
- Funding First funding round.
Competitors of VORTA
VORTA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| aviditybiosciences.com | 2012 | San Diego, United States | $142.54M | 253 | Antibody-siRNA complexes are developed for cancer treatment. | |
| univercells.com | 2013 | Charleroi, Belgium | $150.64M | 87 | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| sutrobio.com | 2003 | United States | $171.85M | 235 | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| vividion.com | 2016 | Oceanside, United States | $270.5M | 123 | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| straumann.com | 1954 | Basel, Switzerland | – | – | Dental implants and regenerative dentistry products are developed. | |
| korrobio.com | 2018 | Cambridge, United States | $4M | 77 | RNA-editing technologies are provided for precision medicine applications. | |
| judges.uk.com | 2002 | London, United Kingdom | – | 622 | Acquisition and development of scientific instrument businesses is conducted. | |
| savarapharma.com | 2008 | Austin, United States | $67.82M | 37 | Therapeutics for rare respiratory diseases are developed by Savara Pharma. | |
| antheia.bio | 2013 | Palo Alto, United States | $152.37M | 50 | Yeast cells are genetically engineered to produce medicinal products. | |
| synthego.com | 2012 | Redwood, United States | $459.75M | – | CRISPR-engineered cell and gene therapies are developed for research applications. |
Detailed competitors of VORTA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to VORTA
10 companies that operate in the same segment as VORTA (Waste & Water Management Systems), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Wastewater and energy management services are provided internationally. | 1853 | Aubervilliers, Seine-saint-denis, France | – | USD 52.17 B | 215,040 | |
Sustainable infrastructure solutions in renewable energy are developed and managed. | 1931 | Alcobendas, Comunidad De Madrid, Spain | – | USD 1.9 M | 44 | |
Provider of climate-smart deeptech solutions for renewable energy and sustainable agriculture | 2010 | Pune, Maharashtra, India | USD 76.38 M | USD 56.11 M | 702 | |
Waste collection and management services are provided nationwide. | 1968 | Houston, Texas, United States | – | USD 25.2 B | 61,700 | |
Integrated waste management services are provided nationwide. | 1998 | Phoenix, Arizona, United States | – | USD 16.59 B | 42,000 | |
Provider of smart water purifier rental and maintenance services | 2016 | Bengaluru, Karnataka, India | USD 19.29 M | USD 3.62 M | – | |
Sensor-based sorting and recycling solutions are provided for multiple industries. | 1972 | Asker, Viken, Norway | – | USD 1.53 B | 4,950 | |
Smart water dispensers with flavored options are provided for offices. | 2013 | Boston, Massachusetts, United States | USD 135.53 M | – | 102 | |
Surplus goods are shared among neighbors through a mobile app. | 2015 | London, England, United Kingdom | USD 51.2 M | – | – | |
Water and waste treatment services are provided worldwide. | 1966 | London, England, United Kingdom | – | USD 4.18 B | 9,750 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about VORTA
VORTA was founded in 2015 and raised its 1st funding round 4 years after it was founded.
VORTA is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
The primary company behind VORTA, Vivira Process Technologies Private Limited, reported revenue of ₹43.7 Lakh for FY 2025, down 43% year on year.
VORTA is engaged in improving operational efficiencies within the manufacturing sector through innovative vortex cavitation technology. Solutions are provided to various industries including oil gas, pharmaceuticals, and dairy, targeting process streams and waste valorization. The technology is applied to enhance productivity, reduce waste, and promote sustainability by maximizing resource utilization. Operations are supported across multiple sectors to address challenges like aging infrastructure and compliance constraints, contributing to the transition towards a circular economy.
VORTA's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
VORTA offers Vortex Cavitation Reactor and Process Stream Optimization.
VORTA has 1 investor. Key investors include Swati Pramod Ranade.
The valuation of VORTA is $36.84K as of Dec 2019.
VORTA operates through Vivira Process Technologies Private Limited.
The legal entities of VORTA currently have 3 directors, including Swati Pramod Ranade, Vivek Vinayak Ranade, Ranjeet Pandurangrao Utikar.